BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26956049)

  • 1. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
    Carter BZ; Mak PY; Chen Y; Mak DH; Mu H; Jacamo R; Ruvolo V; Arold ST; Ladbury JE; Burks JK; Kornblau S; Andreeff M
    Oncotarget; 2016 Apr; 7(15):20054-67. PubMed ID: 26956049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
    Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
    Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.
    Mak PY; Mak DH; Mu H; Shi Y; Ruvolo P; Ruvolo V; Jacamo R; Burks JK; Wei W; Huang X; Kornblau SM; Andreeff M; Carter BZ
    Apoptosis; 2014 Apr; 19(4):698-707. PubMed ID: 24337870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
    Li X; Guo H; Duan H; Yang Y; Meng J; Liu J; Wang C; Xu H
    Sci Rep; 2015 Nov; 5():16228. PubMed ID: 26538086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia.
    Piya S; Andreeff M; Borthakur G
    Autophagy; 2017 Jan; 13(1):214-215. PubMed ID: 27797294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
    Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia.
    Mak PY; Mak DH; Ruvolo V; Jacamo R; Kornblau SM; Kantarjian H; Andreeff M; Carter BZ
    Br J Haematol; 2014 Nov; 167(3):376-84. PubMed ID: 25079338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
    Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
    Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.
    Lopes MR; Pereira JK; de Melo Campos P; Machado-Neto JA; Traina F; Saad ST; Favaro P
    Sci Rep; 2017 Jan; 7():40707. PubMed ID: 28084439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
    Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
    J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
    Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
    PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
    Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
    Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.
    Li J; Volk A; Zhang J; Cannova J; Dai S; Hao C; Hu C; Sun J; Xu Y; Wei W; Breslin P; Nand S; Chen J; Kini A; Zhu J; Zhang J
    Oncotarget; 2017 Jan; 8(5):8420-8435. PubMed ID: 28039479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.
    Piya S; Kornblau SM; Ruvolo VR; Mu H; Ruvolo PP; McQueen T; Davis RE; Hail N; Kantarjian H; Andreeff M; Borthakur G
    Blood; 2016 Sep; 128(9):1260-9. PubMed ID: 27268264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.
    Pang Y; Zhao Y; Wang Y; Wang X; Wang R; Liu N; Li P; Ji M; Ye J; Sun T; Li J; Ma D; Lu F; Ji C
    J Exp Clin Cancer Res; 2020 Aug; 39(1):158. PubMed ID: 32795319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.